New Report: Half of every dollar spent on medicines goes to those that don’t even make medicines.

America’s intellectual property system works wonders, driving:.Innovation 💡.Competition 🔬.And lower costs. 💵

PhRMA Congratulates President Donald Trump on His Inauguration

The Biden administration’s rushed IRA price-setting list highlights a flawed process that risks access to innovation. More than half the medicine targeted are a result of the harmful “pill penalty,” discouraging development of these critical treatments. Seniors deserve better.

Chief Medical Officer @mybarra notes the threat that pharmacy benefit managers and the 340B program pose to patient affordability and access.

A new @nytimes investigation reveals how a for-profit federal contractor helps hospitals abuse the #340B markup program. Policymakers need to hold 340B hospitals and other actors accountable for their greedy behavior.

🚨 FTC finds PBMs raking in billions by marking up lifesaving drugs! 🚨 The three largest PBMs inflated costs of cancer, HIV and critical meds by up to 1,000%, driving up prices for patients and employers. 💰.

RT @steveubl: The new FTC report shows PBMs are marking up essential medicines at the pharmacies they own, making billions in excess revenu….

🚨 New @FTC report found the three biggest PBMs charge massive markups on medicines dispensed at the pharmacies they own, forcing patients & employers to pay more than they should. This adds to the mounting evidence of how PBMs abuse the system. More:.

#ICYMI: Each year, PhRMA celebrates the individuals in our industry who go above and beyond to advance science and support patients through our Working for Cures Employee Champion Awards. Meet the latest winners:

Nonresident Fellow @kjacny of @AEI discusses the advancements made in cancer prevention – including in small molecules – that enable patients to live longer, healthier and more productive lives.

Hear from @EliLillyandCo CEO Dave Ricks about the 340B program and pharmacy benefit managers.

Hear from @canaanpartners General Partner @JuliePapanek on how government price setting in the Inflation Reduction Act jeopardizes the future of small molecule medicine development.

Getting ahead of a disease before it causes long term complications benefits everyone—patients, communities and our entire health care system. Learn more about the power of prevention from PhRMA's Dr. Mike Ybarra, and Dr. Leonard Friedland of @GSK.

#ICYMI: PhRMA joined @colo_politics to discuss how the rapidly growing #340B program leaves Colorado patients and underserved communities behind. Watch the full video:

The analysts at @healthdataatlas provide insight into the #340B finances for a large hospital in Atlanta. Their analysis suggests that the hospital, including its network of cancer centers, generated at least $735 million in 340B profits - shockingly nearly double what the.

Congratulations to PhRMA's president and CEO @steveubl who made the list for Modern Healthcare’s 100 Most Influential People in Healthcare. @modrnhealthcr

New research shows remarkable declines in cervical cancer mortality in young women over the last decade, a credit to the power of lifesaving HPV vaccines. Read more about how vaccines are preventing disease and transforming health outcomes:

A new report from the Minnesota Department of Health shows the #340B program in Minnesota disproportionately benefits large hospital systems and for-profit middlemen, like contract pharmacies and third-party administrators, raising serious concerns about whether vulnerable.